Using the DEGs identified in the BLCA subtype, we built a prognostic risk model comprising four genes (OAS1, AOC2, HSH2D, and HOXB5) and validated it using the E-MTAB-4321 arrayExpress dataset. This evidence concerns the gene HSH2D and bladder transitional cell carcinoma.